increas
left
atrial
pressur
wherea
secondari
pneumonia
occur
mainli
older
adult
patient
comorbid
condit
chronic
cardiovascular
respiratori
diseas
diabet
mellitu
chronic
hepat
renal
failur
typic
present
includ
acut
onset
cough
sore
throat
conjunctiv
hyperemia
nasal
discharg
congest
fever
myalgia
headach
malais
symptom
find
pneumonia
infrequ
diseas
usual
selflimit
reappear
worsen
respiratori
symptom
sign
suggest
pneumonia
radiograph
evid
pneumonia
may
found
absenc
find
typic
radiograph
find
primari
pneumonia
diffus
interstiti
patchi
infiltr
secondari
pneumonia
may
segment
lobar
pattern
primari
secondari
pneumonia
may
occur
patient
time
indirect
diagnosi
use
primarili
epidemiolog
purpos
requir
two
serolog
assay
perform
day
apart
direct
diagnosi
made
cultur
respiratori
secret
lung
tissu
process
take
day
less
antigen
detect
techniqu
use
immunofluoresc
enzymelink
immunosorb
assay
elisa
techniqu
nasal
pharyng
cell
obtain
brush
wash
process
take
approxim
min
antigen
detect
respiratori
secret
less
sensit
rapid
techniqu
addit
support
care
treatment
specif
antivir
therapi
amantadin
mgkg
per
day
day
rimantadin
may
benefici
administ
earli
cours
diseas
within
h
symptom
onset
zanamivir
oseltamivir
relat
antivir
drug
similar
mechan
action
similar
rate
effect
influenza
b
virus
wherea
inhibitor
amantadin
rimantadin
activ
influenza
neuraminidas
inhibitor
zanamivir
inhal
oseltamivir
given
oral
drug
approv
treatment
influenza
person
symptomat
less
day
clinic
studi
show
symptom
influenza
disappear
day
sooner
drugtreat
group
placebo
group
antibiot
activ
pneumonia
h
influenza
aureu
need
treat
patient
secondari
pneumonia
morbid
mortal
influenza
pneumonia
high
patient
deterior
point
acut
respiratori
distress
syndrom
ard
develop
case
likelihood
secondari
pneumonia
develop
high
inactiv
influenza
vaccin
modifi
year
follow
antigen
modif
influenza
strain
provid
protect
influenzarel
ill
protect
influenzarel
hospit
admiss
death
elderli
accordingli
vaccin
recommend
patient
older
year
patient
chronic
comorbid
condit
regardless
age
patient
resid
chronic
care
facil
health
care
worker
increas
risk
contact
patient
influenza
spread
noninfect
patient
prevent
administr
amantadin
rimantadin
week
vaccin
recommend
highrisk
patient
provid
protect
period
requir
develop
effect
immunolog
respons
recent
human
infect
caus
avian
influenza
vietnam
thailand
cambodia
china
indonesia
egypt
turkey
rais
possibl
pandem
near
futur
sever
infect
human
distinguish
caus
routin
season
influenza
respiratori
failur
requir
hospit
intens
care
seen
recogn
case
mortal
high
earli
clinic
featur
infect
includ
persist
fever
cough
respiratori
difficulti
progress
day
well
lymphopenia
admiss
hospit
exposur
sick
die
poultri
area
known
suspect
activ
report
patient
although
recognit
poultri
outbreak
sometim
follow
recognit
human
case
patient
suspect
infect
droplet
precaut
care
routin
infect
control
measur
use
infect
rule
patient
ill
compat
influenza
known
exposur
poultri
area
previou
infect
test
infect
direct
fluoresc
antibodi
test
avail
influenza
requir
approxim
h
detect
anim
subtyp
rapid
bedsid
test
detect
influenza
use
screen
tool
avian
influenza
set
throat
swab
test
revers
transcriptasepolymeras
chain
reaction
rtpcr
sensit
confirm
infect
date
nasopharyng
swab
wash
aspir
bronchoalveolar
lavag
bal
fluid
lung
tissu
stool
yield
posit
result
rtpcr
viral
cultur
vari
sensit
convalescentphas
serum
test
microneutr
antibodi
antigen
small
number
intern
refer
laboratori
specimen
suspect
case
infect
sent
public
health
laboratori
appropri
biocontain
facil
case
discuss
health
depart
offici
arrang
transfer
specimen
initi
epidemiolog
evalu
recommend
test
evolv
basi
featur
pandem
guidanc
sought
center
diseas
control
prevent
cdc
world
health
organ
web
site
http
wwwcdcgov
http
wwwwhoint
patient
confirm
suspect
influenza
treat
oseltamivir
isol
sinc
suscept
neuraminidas
inhibitor
oseltamivir
zanamivir
resist
adamantin
amantadin
rimantadin
patient
suspect
infect
treat
oseltamivir
antibacteri
agent
target
pneumonia
aureu
common
caus
secondari
bacteri
pneumonia
patient
influenza
current
recommend
cours
treatment
standard
dosag
mg
two
time
daili
treatment
recommend
may
vari
consider
chang
pandem
situat
specif
guidanc
found
infecti
diseas
societi
america
idsa
american
thorac
societi
at
cdc
web
site
addit
droplet
precaut
use
patient
suspect
influenza
place
respiratori
isol
etiolog
rule
health
care
personnel
wear
higher
respir
medic
procedur
high
likelihood
gener
infecti
respiratori
aerosol
four
serotyp
identifi
type
respons
infect
human
parainfluenza
virus
respons
respiratori
infect
occur
children
found
infrequ
immunocompet
adult
epidemiolog
clinic
characterist
depend
serotyp
summar
tabl
influenza
parainfluenza
virus
transmit
human
respiratori
secret
incub
period
last
day
humor
local
cellular
immun
gener
neutral
circul
antibodi
local
secretori
iga
cytotox
helper
lymphocyt
respect
adult
diseas
may
complet
asymptomat
may
present
common
upper
respiratori
tract
infect
rhiniti
pharyng
fever
unusu
progress
pneumonia
pneumonia
occur
symptom
sign
nonspecif
chest
radiograph
show
diffus
interstiti
infiltr
consist
type
atyp
viral
pneumonia
although
treatment
ribavirin
tribavirin
vitro
activ
support
corticosteroid
report
anecdot
acceler
recoveri
patient
sever
involv
vaccin
yet
avail
lead
caus
respiratori
tract
infect
young
children
respiratori
syncyti
viru
rsv
respons
hospit
admiss
pneumonia
bronchiol
children
younger
month
old
incub
period
last
day
epidem
occur
late
fall
spring
usual
last
month
almost
children
older
year
antirsv
antibodi
transmitt
rsv
contamin
skin
follow
autoinocul
conjunctiva
nose
aerosol
produc
cough
sneez
immun
involv
mainli
local
serum
antibodi
cellmedi
immun
also
develop
infect
rsv
induc
ige
product
magnitud
predict
risk
subsequ
wheez
episod
usual
rsv
infect
begin
upper
respiratori
tract
nasal
congest
pharyng
associ
fever
variabl
intens
lower
respiratori
tract
rapidli
becom
involv
case
lead
worsen
cough
dyspnea
wheez
rhonchi
hypoxemia
common
two
type
lower
respiratori
tract
involv
occurpneumonia
bronchiol
associ
interstiti
infiltr
former
lung
inflamm
latter
peripher
atelectasi
hyperinfl
older
adult
chronic
cardiopulmonari
diseas
rsv
may
caus
sever
bronchiti
pneumonia
serolog
diagnosi
made
test
may
less
reliabl
children
younger
month
direct
diagnosi
requir
cultur
respiratori
secret
nasopharyng
wash
throat
swab
viru
detect
possibl
day
immunofluoresc
techniqu
frequent
use
allow
reliabl
rapid
detect
nasal
scrape
wash
elisa
assay
less
sensit
treatment
aerosol
ribavirin
improv
clinic
cours
administ
hoursday
day
patient
sever
diseas
system
corticosteroid
also
given
suffer
sever
involv
rsv
may
spread
among
hospit
children
hospit
staff
prevent
nosocomi
infect
recommend
box
vaccin
avail
adenovirus
respons
respiratori
infect
children
account
less
adult
except
militari
recruit
popul
epidem
report
almost
adult
serum
antibodi
adenovirus
usual
sever
serotyp
adenoviru
respiratori
infect
may
consequ
airborn
fecalor
contamin
incub
period
last
day
latent
infect
may
develop
even
implic
pathogenesi
chronic
airway
diseas
asthma
chronic
obstruct
pulmonari
diseas
children
militari
recruit
adenovirus
caus
bronchiol
pneumonia
variabl
sever
rapid
diagnosi
requir
antigen
detect
histopatholog
examin
biopsi
specimen
show
intranuclear
basophil
inclus
viru
isol
requir
day
sever
week
serodiagnosi
requir
acut
convalesc
sera
treatment
support
eg
analges
cough
suppress
effect
entericco
live
vaccin
develop
militari
recruit
use
set
measl
viru
belong
paramyxovirida
famili
therefor
similar
parainfluenza
viru
rsv
portal
entri
respiratori
tract
conjunctiva
lower
respiratori
tract
manifest
affect
patient
measl
includ
mainli
bronchiti
pneumonia
may
complic
bacteri
superinfect
case
unit
state
pneumonia
caus
measlesrel
death
children
patient
measl
show
typic
viral
prodrom
consist
fever
rhiniti
malais
anorexia
last
approxim
week
onset
rash
maculopapular
rash
begin
face
neck
progress
trunk
extrem
leukopenia
seen
earli
measl
pneumonia
caus
hilar
lymphadenopathi
pleural
effus
addit
reticulonodular
parenchym
infiltr
secondari
bacteri
pneumonia
also
occur
treatment
support
antibiot
requir
bacteri
secondari
infect
occur
consist
data
avail
effect
corticosteroid
measl
vaccin
reduc
incid
diseas
develop
countri
shift
median
age
onset
teenag
year
varicella
caus
pneumonia
adult
complic
unusu
immunocompet
children
epidem
occur
winter
spring
infect
rate
exceed
within
first
week
exposur
initi
rash
appear
face
head
subsequ
spread
thorax
abdomen
extrem
rash
rather
orderli
progress
begin
erythemat
macul
progress
vesicl
within
hour
day
subsequ
becom
pustular
final
crust
lesion
may
also
found
mucos
surfac
eg
pharynx
vagina
pneumonia
occur
gener
present
within
first
day
onset
rash
cough
common
pleurit
chest
pain
hemoptysi
may
occur
organ
liver
kidney
heart
brain
may
also
involv
diffus
small
nodular
infiltr
characterist
radiograph
abnorm
hilar
adenopathi
effus
common
resolut
nodul
may
calcifi
persist
life
figur
varicella
infect
diagnos
cytolog
examin
scrape
lesion
eg
tzanck
smear
seek
multinucl
giant
cell
although
sensit
test
low
viru
may
cultur
found
polymeras
chain
reaction
number
serolog
test
avail
includ
fluoresc
antibodi
membran
antigen
test
elisa
treatment
earli
administr
acyclovir
mgkg
intraven
everi
h
day
recommend
immunocompromis
host
varicella
immunocompet
patient
suffer
pneumonia
prevent
administr
oral
acyclovir
adult
varicella
may
prudent
especi
elderli
subject
pregnant
women
patient
chronic
obstruct
pulmonari
diseas
zoster
immun
globulin
recommend
reduc
sever
ill
immunocompromis
patient
expos
varicella
infect
spread
readili
hospit
set
strict
isol
must
institut
lesion
crust
hantaviru
pulmonari
syndrom
first
recogn
unit
state
diseas
retrospect
identifi
use
serolog
test
patient
similar
ill
syndrom
result
sever
hantavirus
sin
nombr
viru
almost
case
report
north
south
america
rodent
eg
field
mice
vole
chipmunk
serv
reservoir
transmiss
human
result
aerosol
virus
contain
fece
persontoperson
spread
rare
ever
occur
initi
present
flulik
syndrom
fever
myalgia
nausea
vomit
gastrointestin
pain
suggest
gastroenter
follow
dri
cough
portend
diffus
noncardiogen
pulmonari
edema
sometim
associ
bilater
pleural
effus
may
lead
ard
shock
sever
case
hematolog
examin
usual
demonstr
neutrophil
leukocytosi
hemoconcentr
thrombocytopenia
circul
immunoblast
renal
failur
may
occur
uncommon
diagnosi
made
serolog
immunohistochem
techniqu
treatment
mainli
support
result
control
trial
intraven
ribavirin
pend
although
vitro
effect
ribavirin
demonstr
preliminari
result
openlabel
trial
impress
avoid
area
infect
rodent
resid
recogn
prevent
measur
outbreak
sar
recent
report
mainli
asian
countri
canada
origin
epidem
believ
guangdong
provinc
china
none
previous
describ
respiratori
pathogen
consist
identifi
new
coronaviru
isol
patient
sar
thought
respons
pathogen
incub
period
rang
day
clinic
present
radiolog
featur
sar
atyp
pneumonia
effect
treatment
avail
despit
use
antivir
therapi
ribavirin
steroid
mani
case
sar
seriou
respiratori
ill
lead
signific
morbid
patient
requir
admiss
intens
care
unit
mortal
rate
approxim
factor
associ
poor
outcom
older
year
signific
comorbid
diabet
mellitu
initi
elev
lactat
dehydrogenas
level
elev
polymorphonuclear
count
sar
highli
transmiss
recommend
patient
isol
singl
room
neg
pressur
possibl
health
care
personnel
wear
glove
gown
mask
eye
protect
wash
hand
care
remov
glove
number
health
care
worker
contact
sar
patient
limit
suspect
confirm
case
report
local
health
author
world
health
organ
commonli
encount
fungal
parasit
pulmonari
infect
summar
tabl
differenti
diagnosi
given
patient
depend
immunolog
statu
geograph
local
travel
histori
number
fungal
pneumonia
occur
almost
exclus
north
america
eg
histoplasmosi
blastomycosi
coccidioidomycosi
although
fungal
parasit
pulmonari
infect
frequent
selflimit
recurr
sever
diseas
common
cellmedi
immun
impair
infect
immunocompromis
patient
cover
chapter
although
amphotericin
b
remain
effect
medic
fungal
infect
treatment
facilit
number
new
agent
easier
administ
better
toler
therapeut
option
summar
tabl
aspergillu
speci
ubiquit
saprophyt
fungi
produc
sever
toxic
substanc
eg
endotoxin
proteas
airway
colon
aspergillu
usual
seen
patient
chronic
lung
lesion
bronchiectat
caviti
pulmonari
fibrosi
tuberculosi
sequela
local
host
defens
impair
invas
aspergillosi
unusu
find
nonneutropen
patient
describ
patient
chronic
obstruct
pulmonari
diseas
longterm
steroid
therapi
nonimmunocompromis
patient
aspergillu
speci
caus
hypersensit
pneumon
gener
aspergillu
fumigatu
ffler
syndrom
discuss
chapter
respect
allerg
bronchopulmonari
aspergillosi
cover
chapter
aspergilloma
chronic
necrot
pneumonia
describ
nonneutropen
patient
preexist
lung
diseas
chronic
steroid
therapi
amphotericin
b
effect
medic
fungal
infect
treatment
facilit
howev
number
new
agent
easier
administ
better
toler
itraconazol
voriconazol
caspofungin
histoplasma
capsulatum
frequent
isol
soil
contamin
bird
bat
fece
provid
organ
nitrogen
necessari
growth
diseas
occur
central
unit
state
estim
preval
incid
infect
respect
mexico
puerto
rico
diseas
initi
seen
rural
commun
found
patient
resid
urban
set
well
particularli
associ
construct
project
involv
move
contamin
soil
numer
occup
increas
risk
exposur
inhal
spore
contain
infect
particl
mm
diamet
ideal
size
reach
airway
alveoli
inhal
multipl
convert
spore
yeast
phagocytos
macrophag
abl
surviv
prolifer
dissemin
metastat
site
liver
spleen
lymphocytemedi
delayedtyp
hypersensit
reaction
occur
result
format
granuloma
resembl
found
mycobacteri
diseas
necrot
materi
may
becom
caseou
calcifi
granuloma
may
found
lung
well
number
site
metastat
infect
patient
affect
compromis
cellular
immun
aid
lymphoma
suscept
histoplasmosi
may
develop
sever
diseas
patient
acut
primari
infect
undiagnos
histoplasmosi
remain
subclin
inhal
larger
number
spore
frequent
result
exposur
close
space
syndrom
develop
approxim
day
later
abrupt
onset
resembl
influenza
bacteri
pneumonia
tuberculosi
tabl
inoculum
particularli
larg
patient
may
ard
develop
growth
histoplasma
speci
slow
sever
week
need
cultur
becom
posit
giemsa
stain
blood
bone
marrow
smear
may
diagnost
fungu
load
high
unusu
immunocompet
patient
tissu
sampl
demonstr
organ
silver
period
acidschiff
pa
stain
indirect
diagnosi
may
provid
sever
serolog
techniqu
includ
complement
fixat
immunodiffus
radioimmunoassay
may
requir
sever
week
becom
posit
treatment
need
patient
chronic
progress
histoplasmosi
dissemin
use
amphotericin
b
limit
need
figur
spleen
occas
mark
hilar
lymphadenopathi
focal
diffus
mediastin
fibrosi
may
compress
central
structur
eg
airway
arteri
vein
esophagu
chronic
progress
diseas
occur
rare
symptom
cough
hemoptysi
dyspnea
fever
chest
radiograph
usual
show
upper
lobe
peripher
area
consolid
evolv
caviti
mimic
heal
tuberculosi
empyema
may
occur
may
broncholithiasi
associ
hemoptysi
bronchial
obstruct
chronic
infect
mening
brain
heart
may
occur
rare
blastomycosi
found
north
america
area
larg
overlap
histoplasmosi
occur
mexico
middl
east
africa
india
result
inhal
blastomyc
dermatitidi
fungu
grow
soil
spore
becom
airborn
inhal
convert
yeast
form
lung
b
dermatitidi
infect
may
occur
sporad
epidem
initi
defens
mechan
involv
polymorphonuclear
cell
follow
macrophag
giant
cell
epithelioid
granuloma
often
develop
depend
type
predomin
inflammatori
respons
pyogen
granulomat
histopatholog
pattern
mimic
bacteri
infect
sarcoidosi
mycobacteri
diseas
multipl
yeast
lung
may
spread
skin
bone
brain
peripher
lymph
node
organ
extrapulmonari
manifest
may
occur
mani
year
initi
infect
clinic
manifest
blastomycosi
differ
one
countri
anoth
north
america
acut
epidem
blastomycosi
mimic
bacteri
pneumonia
abrupt
onset
fever
chill
arthralgia
myalgia
cough
purul
sputum
pleurit
chest
pain
milder
case
frequent
present
chronic
diseas
resembl
tuberculosi
lowgrad
fever
cough
anorexia
weight
loss
develop
insidi
physic
examin
sometim
demonstr
erythema
nodosum
find
pulmonari
consolid
may
normal
radiograph
manifest
nonspecif
includ
caviti
infiltr
round
densiti
consolid
air
bronchogram
perihilar
mass
even
miliari
pattern
mediastin
lymph
node
involv
rare
studi
pleural
effus
quit
uncommon
sever
case
infect
b
dermatitidi
caus
ard
even
immunocompet
host
patient
cutan
blastomycosi
frequent
histori
selflimit
pulmonari
syndrom
occur
year
past
diagnosi
blastomycosi
made
microscop
examin
respiratori
secret
digest
potassium
hydroxid
histopatholog
examin
tissu
sampl
silver
pa
stain
cultur
respiratori
sampl
detect
growth
take
week
blastomycosi
often
selflimit
treatment
restrict
chronic
diseas
sever
acut
infect
itraconazol
best
ratio
efficaci
side
effect
amphotericin
b
prefer
sever
case
ketoconazol
altern
slowli
progress
diseas
coccidioidomycosi
result
anoth
soildwel
fungu
coccidioid
immiti
endem
southwestern
unit
state
northern
mexico
occur
mainli
hot
dri
summer
inhal
airborn
spore
lead
polymorphonuclearmedi
suppur
cellmedi
granulomat
inflammatori
respons
incub
period
day
patient
coccidioidomycosi
may
complain
fever
chill
arthralgia
myalgia
headach
addit
cough
pleurit
chest
pain
dyspnea
occas
hemoptysi
result
area
lung
necrosi
manifest
cavit
physic
examin
may
reveal
macular
rash
erythema
nodosum
erythema
multiform
well
rhonchi
wheez
sign
consolid
pleural
effus
mani
patient
physic
examin
normal
chest
radiograph
initi
show
one
area
consolid
may
cavit
hilar
lymphadenopathi
may
found
caviti
multipl
calcifi
nodul
may
persist
life
occasion
patient
progress
primari
coccidioidomycosi
develop
condit
infiltr
lymphadenopathi
progress
associ
fever
cough
weight
loss
sever
month
primari
pulmonari
infect
dissemin
coccidioidomycosi
may
becom
manifest
affect
skin
bone
joint
genitourinari
system
mening
particularli
exclus
immunocompromis
patient
diagnosi
coccidioidomycosi
may
made
serolog
skin
test
use
epidemiolog
purpos
direct
diagnosi
made
microscop
examin
sputum
pu
potassium
hydroxid
digest
papanicola
stain
histopatholog
examin
tissu
biopsi
silver
stain
cultur
may
demonstr
fungal
growth
day
pose
inhal
risk
laboratori
personnel
treatment
coccidioidomycosi
similar
histoplasmosi
blastomycosi
reli
fluconazol
itraconazol
amphotericin
b
ketoconazol
altern
patient
specif
therapi
requir
coccidioidomycosi
usual
mild
selflimit
except
rare
case
progress
spread
hematogen
dissemin
may
common
darkskin
race
immunocompromis
associ
high
risk
mening
poor
prognosi
paracoccidioidomycosi
result
inhal
soil
fungu
found
mainli
south
central
america
mexico
nonimmunocompromis
patient
paracoccidioidomycosi
present
chronic
subacut
lung
infect
usual
selflimit
immunocompromis
subject
clinic
manifest
acut
sever
dissemin
infect
diagnosi
paracoccidioidomycosi
reli
techniqu
use
coccidioidomycosi
sever
dissemin
case
paracoccidioidomycosi
treatment
similar
coccidioidomycosi
continu
month
cryptococcu
neoforman
found
throughout
world
bird
guano
cryptococcosi
rare
infect
usual
asymptomat
selflimit
immunocompet
patient
impair
cellmedi
immun
may
caus
lung
infect
mening
symptom
pulmonari
infect
includ
fever
malais
cough
chest
pain
chest
radiograph
may
show
larg
nonspecif
nodul
figur
infiltr
sometim
associ
lymphadenopathi
c
neoforman
colon
airway
immunocompromis
patient
chronic
bronchiti
without
caus
ill
accordingli
cultur
fungu
sputum
alway
indic
diseas
cryptococcosi
resolv
spontan
normal
host
patient
chronic
mucopurul
pulmonari
condit
may
colon
cryptococcu
speci
posit
cultur
denot
specif
indic
treatment
patient
progress
diseas
amphotericin
b
ketoconazol
fluconazol
itraconazol
recommend
pulmonari
infect
result
parasit
infrequ
immunocompet
host
must
includ
differenti
diagnosi
patient
live
endem
area
entamoeba
histolytica
endem
west
south
africa
south
southeast
asia
south
america
mexico
diseas
transmit
ingest
contamin
food
water
sexual
transmiss
report
homosexu
men
parasit
dissemin
intestin
liver
much
less
frequent
lung
intestin
infect
brain
pleuropulmonari
complic
occur
patient
liver
abscess
result
either
direct
spread
liver
hematogen
dissemin
main
featur
diseas
intestin
rang
diarrhea
abdomin
cramp
dysenteri
even
intestin
perfor
mucos
ulcer
pleuropulmonari
symptom
includ
cough
dyspnea
pleurit
pain
usual
rightsid
associ
fever
chill
diaphoresi
weight
loss
chest
radiograph
may
show
elev
right
hemidiaphragm
pleural
effus
atelectasi
lung
consolid
usual
affect
right
lower
lobe
lung
abscess
hepatobronchi
fistula
report
patient
pleuropulmonari
complic
amebiasi
find
associ
product
copiou
volum
chocolatecolor
sputum
pericardi
involv
may
observ
patient
diagnosi
made
microscop
examin
stool
sensit
less
serolog
techniqu
sensit
specif
high
invas
diseas
antigen
may
detect
pleural
fluid
respiratori
secret
needl
aspir
lung
liver
abscess
seldom
necessari
drug
choic
treat
invas
amebiasi
metronidazol
mg
everi
h
day
addit
agent
activ
intralumin
protozoa
iodoquinol
diloxanid
paromomycin
pleuropulmonari
complic
result
plasmodium
falciparum
agent
sever
form
malaria
mild
respiratori
involv
probabl
underdiagnos
may
affect
patient
falciparum
malaria
pulmonari
involv
commonli
associ
cerebr
diseas
mark
parasitemia
histopatholog
featur
includ
capillari
congest
pulmonari
edema
alveolar
hemorrhag
endotheli
cell
injuri
pulmonari
manifest
malaria
includ
mild
cough
associ
pleural
effus
lung
consolid
interstiti
infiltr
sever
respiratori
involv
occur
result
lung
edema
pleural
effus
patient
may
present
ard
diagnosi
made
examin
thin
thick
blood
smear
stain
giemsa
wright
stain
besid
support
respiratori
care
treatment
sever
diseas
requir
intraven
quinidin
exchang
transfus
sever
case
depend
region
origin
drugresist
strain
must
consid
altern
treatment
offer
despit
measur
prognosi
malari
lung
remain
poor
estim
worldwid
preval
infect
nematod
ascari
lumbricoid
normal
habitat
adult
worm
jejunum
infect
follow
ingest
embryon
egg
matur
occur
pulmonari
migrat
may
respons
ascari
pneumonia
selflimit
diseas
occur
day
ingest
last
day
sever
week
ascariasi
respons
fflerlik
syndrom
approxim
case
symptom
domin
cough
sometim
hemoptysi
wheez
dyspnea
highgrad
fever
abdomin
pain
nausea
vomit
hepatomegali
may
present
well
varieti
cutan
reaction
eg
urticaria
angioedema
chest
radiograph
show
unilater
bilater
patchi
migratori
peribronchi
infiltr
eosinophilia
may
present
occas
ige
elev
may
found
sputum
analysi
reveal
eosinophil
charcotleyden
crystal
stool
examin
may
neg
earli
stage
ascariasi
pneumonia
requir
specif
treatment
usual
selflimit
bronchodil
corticosteroid
may
use
bronchospasm
present
antihelminth
therapi
necessari
erad
intestin
adult
worm
tabl
although
strongyloid
stercorali
endem
tropic
subtrop
area
strongyloidiasi
less
frequent
ascariasi
ancylostomiasi
life
cycl
parasit
ascari
hookworm
ancylostomiasi
hookworm
infect
may
caus
two
nematod
ancylostoma
duodenal
necat
americanu
preval
life
cycl
similar
ascari
lumbricoid
strongyloid
stercorali
patient
may
asymptomat
experi
fflerlik
syndrom
transient
urticaria
associ
abdomin
symptom
case
massiv
invas
favor
abnorm
cellmedi
immun
malnutritionrel
immunosuppress
lead
much
sever
diseas
term
hyperinfect
syndrom
develop
dissemin
diseas
tabl
diagnosi
made
sputum
stool
examin
duoden
pleural
aspir
serolog
techniqu
may
help
chronic
case
prefer
treatment
thiabendazol
mgkg
everi
h
day
longer
dissemin
diseas
may
repeat
altern
agent
ivermectin
albendazol
human
viscer
larva
migran
caus
toxocara
cani
less
frequent
toxocara
cati
canin
speci
host
nematod
preval
infect
dog
estim
approxim
contamin
human
occur
ingest
egg
contamin
food
soil
larva
migrat
liver
lung
lymphat
blood
vessel
induc
igemedi
immun
respons
rare
case
organ
may
involv
heart
central
nervou
system
cell
infiltr
invad
tissu
mainli
eosinophil
lesser
extent
lymphocyt
clinic
appar
pulmonari
involv
common
case
manifest
cough
wheez
bronchiol
pneumonia
may
result
acut
respiratori
failur
radiograph
manifest
usual
mild
migratori
infiltr
found
respiratori
symptom
system
symptom
includ
weak
malais
anorexia
nausea
vomit
weight
loss
abdomin
pain
behavior
impair
overal
sever
clinic
ill
reflect
extent
infest
toxocara
larva
matur
human
diagnosi
made
serolog
histolog
examin
invad
tissu
mild
case
diseas
selflimit
treatment
requir
sever
affect
patient
corticosteroid
seem
improv
prognosi
prevent
measur
import
limit
spread
diseas
tabl
human
dirofilariasi
consequ
infest
nematod
dirofilaria
immiti
dog
parasit
transmit
mosquito
rare
case
larva
inject
mosquito
human
transport
blood
vessel
pulmonari
circul
caus
thrombosi
clinic
sign
cough
hemoptysi
chest
pain
fever
present
half
affect
patient
chest
radiograph
may
show
peripher
nodul
cm
diamet
may
calcifi
minor
patient
exhibit
peripher
eosinophilia
diagnosi
made
serolog
histolog
examin
lung
tissu
treatment
requir
tropic
pulmonari
eosinophilia
result
infect
wuchereria
bancrofti
brugia
malayi
lymphaticdwel
filaria
found
tropic
subtrop
area
pulmonari
manifest
consequ
hypersensit
reaction
discharg
microfilaria
circul
gravid
femal
filaria
transmiss
mosquito
ingest
microfilaria
inject
larva
bite
human
patient
tropic
eosinophilia
men
lung
involv
case
clinic
manifest
includ
fever
weak
anorexia
weight
loss
cough
wheez
dyspnea
chest
radiograph
usual
show
bilater
basal
interstiti
infiltr
increas
bronchovascular
mark
lymph
node
involv
consolid
infrequ
parasit
may
found
histolog
examin
affect
organ
diagnosi
gener
made
find
high
level
ige
high
titer
antibodi
filaria
clinic
improv
treatment
standard
treatment
diethylcarbamazin
mgkg
bodi
weight
week
altern
mebendazol
levamisol
new
agent
ivermectin
evalu
corticosteroid
antihistamin
may
use
patient
exhibit
allerg
reaction
die
filaria
patient
requir
repeat
cours
treatment
adult
parasit
may
rel
resist
respons
treatment
invers
relat
durat
symptom
paragonimu
speci
frequent
paragonimu
westermani
hermaphrodit
fluke
endem
southeast
asia
south
america
south
africa
transmit
human
ingest
insuffici
cook
crab
crayfish
contain
encyst
parasit
go
lung
intestin
wall
periton
caviti
diaphragm
pleura
ill
may
occur
first
week
infect
parasit
migrat
intestin
lung
occur
symptom
may
includ
abdomin
pain
diarrhea
hypersensit
reaction
urticaria
eosinophilia
fever
chest
pain
cough
hemoptysi
case
howev
symptom
appear
adult
parasit
begin
produc
egg
lung
induc
cough
hemoptysi
chest
radiograph
usual
show
patchi
infiltr
may
progress
caviti
surround
rim
infiltr
ring
cyst
area
fibrosi
pleural
thicken
common
pleural
effus
infrequ
except
seri
south
asian
patient
chest
radiograph
may
normal
case
diagnosi
base
demonstr
egg
bronchial
secret
pleural
fluid
fece
number
serolog
test
also
avail
prefer
treatment
praziquantel
mgkg
everi
h
day
effect
case
bithionol
mgkg
everi
day
week
less
effect
altern
sever
schistosoma
speci
may
pathogen
human
frequent
encount
describ
tabl
parasit
form
releas
snail
asexu
reproduct
occur
penetr
skin
transform
immatur
parasit
transport
blood
matur
venou
plexus
see
tabl
reproduc
egg
deposit
intestin
bladder
depend
site
infect
venou
plexu
egg
turn
induc
overwhelm
granulomat
reaction
may
migrat
liver
caus
portal
hypertens
subsequ
migrat
lung
portosystem
collater
shown
tabl
symptom
depend
stage
diseas
frequent
pulmonari
manifest
pulmonari
hypertens
occur
chronic
stage
infect
schistosoma
mansoni
schistosoma
japonicum
nodular
lesion
also
develop
infest
includ
differenti
diagnosi
pulmonari
nodul
figur
direct
diagnosi
may
base
examin
stool
kato
thick
smear
urin
rectal
biopsi
sever
serolog
techniqu
develop
effect
treatment
praziquantel
dose
depend
schistosoma
speci
see
tabl
cystic
hydatid
diseas
chd
caus
larva
echinococcu
granulosu
alveolar
hydatid
diseas
ahd
caus
echinococcu
multiloculari
platyhelminth
infect
human
ingest
egg
parasit
transport
blood
lymphat
site
mainli
liver
lung
wherea
chd
manifest
growth
larva
form
spheric
cyst
ahd
result
persist
invas
destruct
prolifer
parasit
human
hydatidosi
case
patient
chd
respiratori
involv
ahd
chd
symptom
occur
approxim
case
relat
compress
adjac
structur
complic
ruptur
secondari
infect
accordingli
symptom
includ
chest
pain
cough
expector
cyst
content
eg
grape
skin
dyspnea
hemoptysi
even
near
drown
cyst
fluid
ruptur
may
also
lead
dissemin
cyst
within
lung
hypersensit
reaction
pleural
effus
rare
instanc
hydatid
cyst
may
develop
pleural
space
ruptur
pulmonari
cyst
chest
radiograph
typic
show
round
opac
call
cannonbal
border
calcifi
sharpli
demarc
cyst
may
contain
smaller
daughter
cyst
shown
comput
tomographi
scan
find
allow
chd
differenti
ahd
latter
comput
tomographi
show
less
welldemarc
mass
necrot
center
eosinophilia
frequent
diagnosi
reli
demonstr
associ
hepat
cyst
serolog
test
case
presenc
cyst
materi
sputum
aspir
cyst
avoid
limit
possibl
dissemin
hypersensit
reaction
treatment
choic
surgic
resect
cyst
surgeri
done
cyst
ruptur
parasit
dissemin
prefer
treatment
albendazol
mg
everi
h
mgkg
per
day
week
treatment
cours
may
repeat
lipoid
pneumonia
result
aspir
exogen
lipid
contain
oral
administ
lax
nasal
decongest
histolog
giantcel
inflamm
oilcontain
vacuol
phagocyt
type
ii
cell
metaplasia
degener
arteriolar
bronchial
wall
necrosi
fibrosi
oil
droplet
lipophag
may
transport
lymphat
blood
liver
spleen
kidney
organ
special
stain
allow
exogen
lipoid
pneumonia
distinguish
condit
aris
accumul
endogen
lipid
occasion
occur
set
chronic
primari
lung
inflamm
tabl
symptom
includ
cough
dyspnea
fever
chest
pain
hemoptysi
onset
may
acut
commonli
chronic
accompani
weight
loss
case
diseas
clinic
silent
discov
chest
radiograph
number
radiolog
present
may
found
box
figur
comput
tomographi
magnet
reson
imag
scan
may
use
demonstr
attenu
valu
hounsfield
unit
highintens
signal
slow
decreas
imag
respect
result
low
densiti
fat
sputum
bronchoalveolar
lavag
fluid
transbronchi
biopsi
examin
fatcontain
macrophag
applic
special
stain
import
intervent
stop
administr
caus
agent
corticosteroid
seem
benefici
exogen
lipoid
pneumonia
usual
follow
benign
cours
frequent
encount
complic
bacteri
fungal
mycobacteri
superinfect
respiratori
insuffici
occur
infrequ
unless
condit
far
advanc
eg
year
chronic
aspir
neoplasm
uncommon
use
oilcontain
lax
decongest
discourag
pneumonia
chest
radiographi
dens
consolid
air
bronchogram
ground
glass
infiltr
cavit
interstiti
infiltr
fibrot
infiltr
nodul
mass
atelectasi
emphysema
pleural
effus
patient
liber
appli
petrolatumcontain
nasal
greas
night
bed
husband
document
patient
routin
slept
left
side
comput
tomographi
scan
show
lowdens
consolid
left
lower
lobe
small
left
pleural
effus
